Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This is a biospecimen procurement protocol to characterize the immune response to zoonotic virus exposure in healthy adult humans aged 18 to 65 years with high-risk exposure to animals or their excreta (e.g., guano farming and wet markets), or living within 5 km of animal habitats (e.g., bat caves and bat roosts) in Cambodia.
This is a biospecimen procurement protocol to characterize immune signatures to zoonotic virus exposure in healthy adult humans aged 18 to 65 years who handle suspected infected animals or their excreta, or living within 5 km of animal reservoirs, in Cambodia.
The primary study objective is to characterize immunity to zoonotic viruses, specifically H5N1. To meet this objective, when possible, individuals with the highest likelihood of prior exposure to the viruses of interest (Nipahvirus, bCoVs, H5N1) will be screened for study inclusion. These high-exposure risk behaviors include direct handling of known or suspected infected animals or their excreta. If insufficient individuals meeting these criteria are found, then sampling will include individuals with lower risk exposures, including living or working in areas proximal to (within 5 km of) animal habitats.
All human subjects research activities will be conducted by study personnel within the International Center of Excellence in Research Cambodia, Cambodian CCDC, and the Forestry Administration of the Royal Government of Cambodia. NIH investigators are involved in study design, implementation, analysis of coded samples and data, and writing and dissemination of reports of study results. Although they may support Cambodian investigators in monitoring/oversight capacities, NIH investigators will not be engaged in human subjects research.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Whole blood collection | Procedure | 30 mL at Day 0 with optional visits for up to 2 additional whole blood collections at least 30 days apart |
| Measure | Description | Time Frame |
|---|---|---|
| Antibody binding activity in plasma samples against known immunodominant zoonotic viral proteins | Measured by binding antibody titer greater than cutoffs established from healthy U.S. donors (3 standard deviations above mean signal intensity) to a panel of either henipaviruses, influenza viruses, or sarbecoviruses | Day 0 and 2 optional visits at least 30 days apart between Day 180-720 |
| Neutralizing activity of plasma samples against known immunodominant zoonotic viral proteins | Measured by circulating antigen-specific B cells constituting approximately 0.001%-0.005% total PBMCs | Day 0 and 2 optional visits at least 30 days apart between Day 180-720 |
| Isolate viral antigen-specific B cells for phenotyping and immunoglobulin sequencing | Measured by isolation of an expected 20 million PBMCs from whole blood samples, yielding approximately 100-500 antigen-specific B cells for single-cell B-cell sequencing (anticipated cell death up to 50% during the isolation and sorting process) | Day 0 and 2 optional visits at least 30 days apart between Day 180-720 |
Not provided
Not provided
Inclusion Criteria:
Capacity to provide informed consent.
Adult aged 18-65 years.
Have interaction with suspected infected animals within the last 2 years, including (but not limited to) the following risk factors:
Willing to allow biological samples and data to be stored for future research.
Exclusion Criteria:
Not provided
Not provided
Healthy adults aged 18 to 65 years who handle suspected infected animals or their excreta, or living within 5 km of animal reservoirs, in Cambodia (n=160 to 320).
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Chanthap Lon, MD | Contact | 85512976799 | lonc@icercambodia.org |
| Name | Affiliation | Role |
|---|---|---|
| Christina Yek, MD | NIH/NIAID/Laboratory of Malaria and Vector Research (LMVR) | Principal Investigator |
| Lon Chanthap, MD | Malaria Vector & Research Laboratory (MVRL) International Center of Excellence in Research Cambodia |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Communicable Disease Control Department | Recruiting | Battambang | Cambodia |
Data from this study may be requested from other researchers 5 years following completion of the primary endpoint by contacting the Principal Investigators.
5 years following completion of the primary endpoint
Researchers should contact the Principal Investigators with data requests.
Not provided
Not provided
Not provided
Not provided
Not provided
Whole blood
| Ly Sovann, MD, MTCM | Cambodian Center for Communicable Disease (CCDC) Ministry of Health, Cambodia | Principal Investigator |
| Communicable Disease Control Department | Recruiting | Kampong Thom | Cambodia |
|
| Communicable Disease Control Department | Recruiting | Kampot | Cambodia |
|
| Communicable Disease Control Department | Recruiting | Stung Treng | Cambodia |
|
| Communicable Disease Control Department | Recruiting | Takeo | Cambodia |
|